Queer quit: a pilot study of a smoking cessation programme tailored to gay men

BMC Public Health

Michael P Schaub²  Benedikt Zahno¹  Robin Sullivan²  Maria Dickson-Spillmann² 

[1] Checkpoint Zurich, Konradstrasse 1, 8005 Zurich, Switzerland;Swiss Research Institute for Public Health and Addiction, Konradstrasse 32, 8031 Zurich, Switzerland

关键词: Pilot project;    Homosexuality;    Smoking cessation;   

Others  :  1161256
DOI  :  10.1186/1471-2458-14-126

 received in 2013-06-19, accepted in 2014-02-04,  发布年份 2014

【 摘 要 】

Background

The prevalence of cigarette smoking among adult gay males is higher than that of heterosexuals. There is a need for interventions adapted to gay culture. We conducted a pilot study using a modified version of a British smoking intervention programme tailored to gay men in Switzerland. As the main outcome, we assessed point prevalence smoking abstinence six months following programme attendance.

Methods

Seventy gay smokers attended seven weekly sessions in groups (median size = 5) taught by gay facilitators. A quit day was set in session 3. Integral components of the intervention were: discussing nicotine replacement therapy, performing carbon monoxide tests and forming ‘quit teams’. Seven-day point prevalence smoking abstinence, mental and physical health and the frequency of alcohol and drug use were assessed at baseline, in session 7 and at a six-month follow-up.

Results

Point prevalence abstinence significantly increased throughout the study (p = .00). At six months, 20 participants (28.6%) reported smoking abstinence over the previous 7 days. We observed increases in participants’ mental health between baseline and the six-month follow-up (p = .00). Participants who dropped out during the programme or were lost to follow-up smoked more cigarettes and were more nicotine dependent than the participants who were retained throughout the study duration (p ≤ .05).

Conclusions

This smoking cessation programme for gay men produced rates of point prevalence abstinence that were similar to interventions for non-gay groups. The programme presented an opportunity for gay men to quit smoking and interact with other gay non-smokers. Our results confirm the need to test this programme more systematically with a view toward implementing it on a larger scale in Switzerland.

Trial registration

Current Controlled Trials ISRCTN36851118 (02 October 2013).

【 授权许可】

   
2014 Dickson-Spillmann et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Tang H, Greenwood GL, Cowling DW, Lloyd JC, Roeseler AG, Bal DG: Cigarette smoking among lesbians, gays, and bisexuals: how serious a problem? (United States). Cancer Causes Control 2004, 15:797-803.
• [2]King BA, Dube SR, Tynan MA: Current tobacco use among adults in the United States: findings from the national adult tobacco survey. Am J Public Health 2012, 102:e93-e100.
• [3]D’Augelli AR: High tobacco use among lesbian, gay, and bisexual youth: mounting evidence about a hidden population’s health risk behavior. Arch Pediatr Adolesc Med 2004, 158:309-310.
• [4]McKirnan DJ, Tolou-Shams M, Turner L, Dyslin K, Hope B: Elevated risk for tobacco use among men who have sex with men is mediated by demographic and psychosocial variables. Subst Use Misuse 2006, 41:1197-1208.
• [5]Gruskin EP, Greenwood GL, Matevia M, Pollack LM, Bye LL: Disparities in smoking between the lesbian, gay, and bisexual population and the general population in California. Am J Public Health 2007, 97:1496-1502.
• [6]Wang J, Häusermann M, Vounatsou P, Aggleton P, Weiss MG: Health status, behavior, and care utilization in the Geneva Gay Men’s Health Survey. Prev Med (Baltim) 2007, 44:70-75.
• [7]National Institutes of Health: National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control. Ann Intern Med 2006, 145:839-844.
• [8]Harding R, Bensley J, Corrigan N: Targeting smoking cessation to high prevalence communities: outcomes from a pilot intervention for gay men. BMC Public Health 2004, 4:43. BioMed Central Full Text
• [9]Schwappach DLB: Queer quit: gay smokers’ perspectives on a culturally specific smoking cessation service. Heal Expect 2009, 12:383-395.
• [10]Bostwick WB, Boyd CJ, Hughes TL, McCabe SE: Dimensions of sexual orientation and the prevalence of mood and anxiety disorders in the United States. Am J Public Health 2010, 100:468-475.
• [11]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127.
• [12]Schmitt M, Altstötter-Gleich C, Hinz A, Maes J, Brähler E: Normwerte für das Vereinfachte Beck-Depressions-Inventar (BDI-V) in der Allgemeinbevölkerung. Diagnostica 2006, 52:51-59.
• [13]Beck AT, Steer RA: Beck Depression Inventory (BDI). San Antonio: The Psychological Corporation Inc.; 1987.
• [14]Margraf J, Ehlers A: Deutschsprachige Adaptation Des Beck Anxiety Inventory [German Adaptation of the Beck Anxiety Inventory (BAI)]. Bern: Huber; 1995.
• [15]Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
• [16]Bullinger M, Kirchberger I, Ware J: Der deutsche SF-36 Health Survey. Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instrumentes zur Erfassung der gesundheitsbezogenen Lebensqualität. Zeitschrift für Gesundheitswissenschaften 1995, 1/95:21-36.
• [17]Jj W, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
• [18]Kokkevi A, Hartgers C: EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res 1995, 1:208-210.
• [19]Ware JE, Kosinski M, Turner-Bowker DM, Gandek B: How to Score Version 2 of the SF-12® Health Survey. QualityMetric Inc: Lincoln, RI; 2002.
• [20]Cropsey KL, Eldridge GD, Weaver MF, Villalobos GC, Stitzer ML: Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res 2006, 8:653-659.
• [21]Javors M a, Hatch JP, Lamb RJ: Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005, 100:159-167.
• [22]Huber D, Gastner J: Raucherentwöhnung: ein empirischer Vergleich von Verhaltenstherapie, Nikotinersatz und deren Kombination [Smoking cessation: a comparison of behavior therapy, nicotine replacement therapy and their combination]. Verhal und Verhal 2003, 24:167-185.
• [23]Schmitz JM, Stotts AL, Mooney ME, Delaune K a, Moeller GF: Bupropion and cognitive-behavioral therapy for smoking cessation in women. Nicotine Tob Res 2007, 9:699-709.
• [24]Romand R, Gourgou S, Sancho-Garnier H: A randomized trial assessing the Five-Day Plan for smoking cessation. Addiction 2005, 100:1546-1554.
• [25]Reynoso J, Susabda A, Cepeda-Benito A: Gender differences in smoking cessation. J Psychopathol Behav Assess 2005, 27:227-234.
• [26]Leventhal AM, Ramsey SE, Brown RA, LaChance HR, Kahler CW: Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res 2008, 10:507-517.
• [27]Killen JD, Fortmann SP, Kraemer HC, Varady a, Newman B: Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. J Consult Clin Psychol 1992, 60:797-801.
• [28]Covey LS, Weissman J, LoDuca C, Duan N: A comparison of abstinence outcomes among gay/bisexual and heterosexual male smokers in an intensive, non-tailored smoking cessation study. Nicotine Tob Res 2009, 11:1374-1377.
• [29]Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2008 2008. Issue 1. Art. No. CD000146. doi:10.1002/14651858.CD000146.pub3
• [30]Lifson AR, Lando HA: Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep 2012, 9:223-230.
• [31]Shuter J, Bernstein SL: Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 2008, 10:731-736.